MOLEKUL / PEPTIDE RESEARCH

Peptide research guide

A guide to the peptide and bioregulator records in Molekul’s Soviet and Russian pharmacology collection.

Explore individual preparations, original-language publications and research settings. Similar names or classifications do not establish equivalent composition, effects or safety.

READ THE RESEARCH
EXPANDED ARCHIVE / OCTOBER 2026

Tissue extracts, defined peptides and cyclic candidates.

The expanded collection follows historical marrow and thymus preparations, newer synthetic candidates and tissue-product reports. Shared tissue targets do not establish identical molecules or a continuous development lineage.

Educational information only. Not medical advice. Seek qualified healthcare help for any medical condition. Experimental radiation, heat and hematopoietic findings do not establish safe personal use or protection from hazardous exposure.
Research branches and their evidence boundaries
BranchPreparationsWhat remains unresolved
Historical tissue mixturesHaemalin, Thymalin, Thymohaemin, Vilosen, Vasonin, TactivinExact composition, formulation continuity, clinical allocation and original archival methods.
Defined small peptidesThymogen, Stemokin / Neogen, Thymodepressin, Thymohexin, EDLSequence, stereochemistry and bond position matter. Opposite assay responses do not establish a common receptor.
Cyclic candidatesCP-88, AWE18 and numbered experimental analoguesOral activity in animals is not measured human bioavailability. CD34 changes and colonies do not prove long-term stem-cell regeneration.
Named tissue productsGotratix, Cerluten, Endoluten, Svetinorm and related preparationsInstitutional reports, commercial reproductions and independent journal studies must remain distinguishable.

Additional preparation records

Haemalin ↗

Research profile with linked sources

Historical bone-marrow peptide mixture; distinct from modern Bonomarlot.

Thymohaemin ↗

Research profile with linked sources

Historical combined thymus and bone-marrow preparation studied alongside Thymalin and Haemalin.

Thymohexin ↗

Research profile with linked sources

Synthetic hexapeptide investigated in radiation-related hematopoietic models. Original sequence verification is needed because Asp and Asn renderings conflict.

Vasonin ↗

Research profile with linked sources

Historical vascular-wall polypeptide research lead. Exact preparation and its relationship to Vasolin require original-source verification.

Vilosen ↗

Research profile with linked sources

Animal-thymus nonprotein extract reported in asthma, hepatitis and immune research. Historical clinical reports include combinations with Splenin; it is distinct from synthetic Vilon.

Tactivin ↗

Research profile with linked sources

Thymus-derived polypeptide preparation studied as an immune adjunct and in animal learning models. Clinical findings include a reported infection reduction in leukemia and a neutral melanoma comparison.

Thymodepressin ↗

Research profile with linked sources

Synthetic γ-D-Glu-D-Trp immunosuppressive dipeptide. Russian reports cover psoriasis, autoimmune cytopenias and myositis; a rheumatoid arthritis trial registration has no verified results.

Stemokin / Neogen ↗

Research profile with linked sources

Synthetic Ile–Glu–Trp tripeptide (IEW), studied in hematopoietic experiments and Russian clinical immune research. It is distinct from whole tissue extracts.

CP-88 ↗

Research profile with linked sources

Experimental cyclic peptidomimetic cyclo-{E(I)-E(W)}Na studied in mouse and laboratory hematopoietic assays. Human efficacy and safety are not established here.

AWE18 ↗

Research profile with linked sources

Experimental cyclic Ala/Glu/Trp peptidomimetic discussed in the development literature. Its evidence must remain separate from CP-88.

EDL ↗

Research profile with linked sources

Glu–Asp–Leu tripeptide studied in renal-cell aging models. It is distinct from AED/Cartalax.

Osteogenic growth peptide ↗

Research profile with linked sources

An international peptide-research comparator with original osteoblast and rodent studies. Full-length OGP, its active fragment and marrow extracts are distinct research preparations.

Gotratix ↗

Research profile with linked sources

A named tissue-derived preparation with a recovered institute report. The linked evidence concerns this preparation and its study setting; clinical effectiveness remains uncertain.

Sigumir ↗

Research profile with linked sources

A named tissue-derived preparation with a recovered institute report. The linked evidence concerns this preparation and its study setting; clinical effectiveness remains uncertain.

Taxorest ↗

Research profile with linked sources

A named tissue-derived preparation with a recovered institute report. The linked evidence concerns this preparation and its study setting; clinical effectiveness remains uncertain.

Chelohart ↗

Research profile with linked sources

A named tissue-derived preparation with a recovered institute report. The linked evidence concerns this preparation and its study setting; clinical effectiveness remains uncertain.

Suprefort ↗

Research profile with linked sources

A named tissue-derived preparation with a recovered institute report. The linked evidence concerns this preparation and its study setting; clinical effectiveness remains uncertain.

Ventfort ↗

Research profile with linked sources

A named tissue-derived preparation with a recovered institute report. The linked evidence concerns this preparation and its study setting; clinical effectiveness remains uncertain.

Endoluten ↗

Research profile with linked sources

Pineal-derived low-molecular-weight peptide mixture named in the original 113-worker Gazprom program. The paper reports program-level sick leave, without an Endoluten-specific effect.

Svetinorm ↗

Research profile with linked sources

A named tissue-derived preparation with a recovered institute report. The linked evidence concerns this preparation and its study setting; clinical effectiveness remains uncertain.

Cerluten ↗

Research profile with linked sources

Brain-associated tissue-peptide preparation named in risk-based assignments in the 113-worker Gazprom program and in institute reports. Shared program findings do not isolate Cerluten.

Vladonix ↗

Research profile with linked sources

A named tissue-derived preparation with a recovered institute report. The linked evidence concerns this preparation and its study setting; clinical effectiveness remains uncertain.

Visoluten ↗

Research profile with linked sources

A named tissue-derived preparation with an institute-attributed clinical report reproduced in a commercial brochure. Reported findings and provenance limits are separated below.

Pielotax ↗

Research profile with linked sources

A named tissue-derived preparation with a recovered institute report. The linked evidence concerns this preparation and its study setting; clinical effectiveness remains uncertain.

Glandokort ↗

Research profile with linked sources

A named tissue-derived preparation with a recovered institute report. The linked evidence concerns this preparation and its study setting; clinical effectiveness remains uncertain.

Bonomarlot ↗

Research profile with linked sources

Animal bone-marrow peptide mixture described in an institute anemia report. It is distinct from synthetic Stemokin and from historical Haemalin.

Bonothyrk ↗

Research profile with linked sources

A named tissue-derived preparation with an institute-attributed clinical report reproduced in a commercial brochure. Reported findings and provenance limits are separated below.

Stamakort ↗

Research profile with linked sources

A named tissue-derived preparation with an institute-attributed clinical report reproduced in a commercial brochure. Reported findings and provenance limits are separated below.

Chitomur ↗

Research profile with linked sources

A named tissue-preparation research lead associated with urinary bladder. Original report and marketed formulation require separate verification; no equivalence to a single synthetic peptide is assumed.

Testoluten ↗

Research profile with linked sources

A named tissue-derived preparation with an institute-attributed clinical report reproduced in a commercial brochure. Reported findings and provenance limits are separated below.

Zhenoluten ↗

Research profile with linked sources

A named tissue-derived preparation with an institute-attributed clinical report reproduced in a commercial brochure. Reported findings and provenance limits are separated below.

Tireogen ↗

Research profile with linked sources

A named tissue-derived preparation with an institute-attributed clinical report reproduced in a commercial brochure. Reported findings and provenance limits are separated below.

Libidon ↗

Research profile with linked sources

A prostate-derived peptide mixture described in a Russian institute-report reproduction. It is a distinct preparation from Prostatilen and the synthetic peptide Prostamax.

Publications added to the archive

These are publication records, not a count of independent trials. Reprints, translations, reviews and potentially overlapping cohorts are not independent replications.

Open questions and sources to locate

Original-source review pending

Tissue-preparation clinical reports

Gotratix, Sigumir, Taxorest, Chelohart, Suprefort, Ventfort, Endoluten, Svetinorm, Cerluten, Vladonix, Visoluten, Pielotax, Glandokort and Bonomarlot

Recover the complete 2011 report collection and verify preparation, allocation and tables. Commercial mirrors are copies, not independent trials. Gotratix sample counts conflict; Cerluten EEG subsets and attention measures require separate denominators; Endoluten hormone changes do not establish cancer treatment. Svetinorm within-group changes must not be presented as between-group benefits. Bonomarlot is an adjunctive iron-treatment report, not marrow regeneration.

Source details ↗
Original-source review pending

Stemokin clinical source lineage

2011 Kakhishvili dissertation → 2015 conference report

Recover Chapter 5, randomization and blinding details, participant overlap, immune-marker tables and occupational-stress measures. Cortisol changes alongside infection treatment cannot establish a direct hormonal effect or improved performance. Locate the 2007, 2010 and 2011 related publications before adding independent-study counts.

Source details ↗
Original-source review pending

Cyclic platform and patent families

IsoNeogen; A1–A5; B1/B5/B6/B9; E1/E3

These are unresolved family/designation leads, not verified synonyms for the numbered 2016 compounds 3–7. Match chemical structures and experimental endpoints before creating individual compound identities. Patent claims are not clinical results.

Source details ↗
Original-source review pending

Neogen vaccine-adjuvant branch

Neogen / modified-linkage candidates

Separate mouse antibody and human-cell experiments from clinical vaccination outcomes. A strong vaccine-only response and timing-dependent effects complicate interpretation.

Source details ↗
Original-source review pending

DSIP archival expansion

Sametsky 1996; Lysenko 1993; adaptation monographs; ID1/ID3/ID8

Acquire original dissertations and books before transferring results to ordinary DSIP. Hyperoxia is distinct from hypoxia. Age-dependent analogue effects, thermoregulation and combination studies require preparation-specific records.

Source details ↗
Original-source review pending

Additional catalogue identities

Ensil, Panaxod, Reviplant, Tireogen, Libidon, Bonothyrk, Stamakort, Chitomur, Testoluten and Zhenoluten

Names alone do not establish peptide composition, tissue origin, regulatory status or efficacy. Catalogue leads remain explicitly unresolved; non-peptide products must not be classified by association.

Original-source review pending

Existing bioregulator evidence

Pancragen, Retinalamin, Epitalon, Cartalax, Thymalin and Vilon

Retain existing primary records and check formulation, cohort overlap and neutral endpoints. Pancragen KEDW and amidated formulations need source-level distinction. Retinalamin active-route comparisons are not untreated controls; extract outcomes do not transfer to defined peptides.

Original-source review pending

Older peptide programs

Vasonin, Vilosen, Tactivin, Thymohexin and OGP

Recover original vascular/coagulation, thymic and marrow studies. Avoid assuming a molecular lineage from a shared tissue target. Thymohexin sequence ambiguity remains open; OGP is a separate international comparator.

Explore peptide research profiles

Cortexin ↗

Кортексин · Research profile with linked sources

Semax ↗

Семакс · Research profile with linked sources

Pinealon ↗

Пинеалон · Research profile with linked sources

Epitalon ↗

Эпиталон · Research profile with linked sources

Thymalin ↗

Тималин · Research profile with linked sources

Vilon ↗

Вилон · Research profile with linked sources

Vesugen ↗

Везуген · Research profile with linked sources

Selank ↗

Селанк · Research profile with linked sources

Thymogen ↗

Тимоген · Research profile with linked sources

Normophthal ↗

Нормофтал · Research profile with linked sources

Cartalax ↗

Карталакс · Research profile with linked sources

Chonluten ↗

Хонлутен · Research profile with linked sources

Prostamax ↗

Простамакс · Research profile with linked sources

Livagen ↗

Ливаген · Research profile with linked sources

Cortagen ↗

Кортаген · Research profile with linked sources

Pancragen ↗

Панкраген · Research profile with linked sources

Cardiogen ↗

Кардиоген · Research profile with linked sources

Testagen ↗

Тестаген · Research profile with linked sources

Bronchogen ↗

Бронхоген · Research profile with linked sources

Cerebrolysin ↗

Церебролизин · Research profile with linked sources

KED ↗

Пептид KED · Research profile with linked sources

PCC ↗

Полипептидный комплекс хрящевой ткани · Research profile with linked sources

Epithalamin ↗

Эпиталамин · Research profile with linked sources

Vasolin / Slavinorm ↗

Вазолин / Славинорм · Research profile with linked sources

Ventvil ↗

Вентвил · Research profile with linked sources

Prostatilen ↗

Простатилен · Research profile with linked sources

Retinalamin ↗

Ретиналамин · Research profile with linked sources

Ovagen ↗

Оваген · Research profile with linked sources

Crystagen ↗

Кристаген · Research profile with linked sources

DSIP ↗

Дельта-сон-индуцирующий пептид · Research profile with linked sources

Haemalin ↗

Гемалин · Research profile with linked sources

Thymohaemin ↗

Тимогемин · Research profile with linked sources

Thymohexin ↗

Тимогексин · Research profile with linked sources

Vasonin ↗

Вазонин · Research profile with linked sources

Vilosen ↗

Вилозен · Research profile with linked sources

Tactivin ↗

Тактивин · Research profile with linked sources

Thymodepressin ↗

Тимодепрессин · Research profile with linked sources

Stemokin / Neogen ↗

Стемокин / Неоген · Research profile with linked sources

CP-88 ↗

Пептидомиметик CP-88 · Research profile with linked sources

AWE18 ↗

Пептидомиметик AWE18 · Research profile with linked sources

EDL ↗

Пептид EDL · Research profile with linked sources

Osteogenic growth peptide ↗

Остеогенный ростовой пептид · Research profile with linked sources

Gotratix ↗

Готратикс · Research profile with linked sources

Sigumir ↗

Сигумир · Research profile with linked sources

Taxorest ↗

Таксорест · Research profile with linked sources

Chelohart ↗

Челохарт · Research profile with linked sources

Suprefort ↗

Супрефорт · Research profile with linked sources

Ventfort ↗

Вентфорт · Research profile with linked sources

Endoluten ↗

Эндолутен · Research profile with linked sources

Svetinorm ↗

Светинорм · Research profile with linked sources

Cerluten ↗

Церлутен · Research profile with linked sources

Vladonix ↗

Владоникс · Research profile with linked sources

Visoluten ↗

Визолутен · Research profile with linked sources

Pielotax ↗

Пиелотакс · Research profile with linked sources

Glandokort ↗

Гландокорт · Research profile with linked sources

Bonomarlot ↗

Бономарлот · Research profile with linked sources

Bonothyrk ↗

Бонотирк · Research profile with linked sources

Stamakort ↗

Стамакорт · Research profile with linked sources

Chitomur ↗

Читомур · Research profile with linked sources

Testoluten ↗

Тестолутен · Research profile with linked sources

Zhenoluten ↗

Женолутен · Research profile with linked sources

Tireogen ↗

Тиреоген · Research profile with linked sources

Libidon ↗

Либидон · Research profile with linked sources

GHK-Cu & GHK family ↗

GHK и структурные аналоги · Research profile with linked sources

Ms13-1 ↗

Пептид Ms13-1 · Research profile with linked sources

HCIQ2c1 ↗

Пептид HCIQ2c1 · Research profile with linked sources

M2IP ↗

Пептид M2IP · Research profile with linked sources

Nephropept ↗

Нефропепт · Research profile with linked sources

Prostateks ↗

Простатекс · Research profile with linked sources

Pineamin ↗

Пинеамин · Research profile with linked sources

NGF mimetics: GK & GTS series ↗

Миметики ФРН · Research profile with linked sources

BDNF mimetics: GSB, GBK & GTS ↗

Миметики BDNF · Research profile with linked sources

NT-3 mimetics: GTS-301 & GTS-302 ↗

ГТС-301 / ГТС-302 · Research profile with linked sources

GZS-411 ↗

ГЗС-411 · Research profile with linked sources

CPG & GZK-111 ↗

ЦПГ / ГЗК-111 · Research profile with linked sources

Glyprolins & PGP hybrids ↗

Глипролины · Research profile with linked sources

Myelopid & MP-1–MP-6 ↗

Миелопид / миелопептиды · Research profile with linked sources

GB-115 & CCK analogues ↗

ГБ-115 · Research profile with linked sources

Liberol / TRH research ↗

Либерол · Research profile with linked sources

Bestim ↗

Бестим · Research profile with linked sources

Imunofan ↗

Имунофан · Research profile with linked sources

Gepon & ezrin-derived peptides ↗

Гепон · Research profile with linked sources

APHC peptide family ↗

Пептиды APHC · Research profile with linked sources

Hcr ASIC peptide family ↗

Пептиды Hcr · Research profile with linked sources

Ueq 12-1 ↗

Пептид Ueq 12-1 · Research profile with linked sources

PPK-V & brain peptide complexes ↗

ППК «В» и экспериментальные полипептидные комплексы мозга · Research profile with linked sources

Xemys ↗

Ксемис · Research profile with linked sources

HAEE ↗

Пептид HAEE · Research profile with linked sources

HAEEPGP ↗

Пептид HAEEPGP · Research profile with linked sources

Rumalon ↗

Румалон · Research profile with linked sources

How to read this research

Check whether a source describes humans, animals, cells, or a review of earlier work. Then examine the population, comparison, measured outcomes, and access to the complete methods. An English abstract can help locate a paper but cannot replace its full report.

Human research in a particular clinical condition does not establish benefit for healthy people or for other conditions. The personal sleep diary is a separate observational record, not clinical evidence for a peptide.

Read our editorial policy ↗